SPC329
Delafloxasín eða lyfjafræðilega viðunandi salt eða ester þar af, þar með talið delafloxasínmeglúmín
Status:
VeittApplication date:
9.2.2021Application published:
15.3.2021Grant published:
15.4.2023
Max expiry date:
22.9.2034Medicine name:
QuofenixMedicine for children:
No
Timeline
Today
9.2.2021Application
15.3.2021Publication
15.4.2023Registration
22.9.2034Expires
Marketing license
IS authorization number:
EU/1/19/1393/001; EU/1/19/1393/002-007Date:
30.12.2019
Foreign authorization number:
EU/1/19/1393Date:
16.12.2019
Owner
Name:
Melinta Subsidiary Corp.Address:
389 Interpace Parkway, Suite 450, Parsippany, NJ 07054 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3214083
Deadlines
TypeDeadline until
Type: Frestur til að fara yfir drög að vottorði
Deadline until: 01.04.2023
Type: Frestur til að svara höfnun, fyrsti
Deadline until: 09.03.2023